Aug 2026
Comparative Effectiveness of Combination Therapy in Patients with Chronic Kidney Disease and Diabetes mellitus Type 2 using Real World Data.
BACKGROUND AND HYPOTHESIS Diabetes mellitus type 2 (T2DM) is the primary driver of chronic kidney disease (CKD). Renin-angiotensin-aldosterone system inhibitors (RAASi) represent basic therapy for CKD in T2DM. Recent studies demonstrated renal benefits of sodium glucose cotransporter 2 inhibitors (SGLT-2i) and glucagon...
J. Casper, Julian Doricic, Zhe-Jia Tian et al.
· Nephrology, Dialysis and Tra... · 0 citations